144 related articles for article (PubMed ID: 15711199)
21. Immunology insights into cardiac allograft rejection.
Savasta M; Lentini S
Rev Cardiovasc Med; 2011; 12(2):e68-76. PubMed ID: 21796085
[TBL] [Abstract][Full Text] [Related]
22. Maintenance immunosuppression with mycophenolate mofetil: long-term efficacy and safety after heart transplantation.
Dandel M; Jasaityte R; Lehmkuhl H; Knosalla C; Hetzer R
Transplant Proc; 2009; 41(6):2585-8. PubMed ID: 19715979
[TBL] [Abstract][Full Text] [Related]
23. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction.
Schowengerdt KO; Ni J; Denfield SW; Gajarski RJ; Radovancevic B; Frazier HO; Demmler GJ; Kearney D; Bricker JT; Towbin JA
J Heart Lung Transplant; 1996 Feb; 15(2):111-23. PubMed ID: 8672514
[TBL] [Abstract][Full Text] [Related]
24. Cardiac allograft rejection: do trough cyclosporine levels correlate with the grade of histologic rejection?
el Gamel A; Keevil B; Rahman A; Campbell C; Deiraniya A; Yonan N
J Heart Lung Transplant; 1997 Mar; 16(3):268-74. PubMed ID: 9087869
[TBL] [Abstract][Full Text] [Related]
25. Survival and incidence of acute rejection in heart transplant recipients undergoing successful withdrawal from steroid therapy.
Felkel TO; Smith AL; Reichenspurner HC; LaFleur B; Lutz JF; Kanter KR; Gravanis MB; Johnston TS
J Heart Lung Transplant; 2002 May; 21(5):530-9. PubMed ID: 11983542
[TBL] [Abstract][Full Text] [Related]
26. Natural history of focal moderate cardiac allograft rejection. Is treatment warranted?
Winters GL; Loh E; Schoen FJ
Circulation; 1995 Apr; 91(7):1975-80. PubMed ID: 7895355
[TBL] [Abstract][Full Text] [Related]
27. Management of children undergoing cardiac transplantation with high Panel Reactive Antibodies.
Asante-Korang A; Jacobs JP; Ringewald J; Carapellucci J; Rosenberg K; McKenna D; McCormack J; Wilmot I; Gjeldum A; Lopez-Cepero M; Sleasman J
Cardiol Young; 2011 Dec; 21 Suppl 2():124-32. PubMed ID: 22152539
[TBL] [Abstract][Full Text] [Related]
28. Tacrolimus: a further update of its use in the management of organ transplantation.
Scott LJ; McKeage K; Keam SJ; Plosker GL
Drugs; 2003; 63(12):1247-97. PubMed ID: 12790696
[TBL] [Abstract][Full Text] [Related]
29. The challenge of rejection and cardiac allograft vasculopathy.
Cotts WG; Johnson MR
Heart Fail Rev; 2001 Sep; 6(3):227-40. PubMed ID: 11391041
[TBL] [Abstract][Full Text] [Related]
30. Allograft rejection of ISHLT grade >/=3A occurring late after heart transplantation--a distinct entity?
Klingenberg R; Koch A; Schnabel PA; Zimmermann R; Sack FU; Haass M; Dengler TJ
J Heart Lung Transplant; 2003 Sep; 22(9):1005-13. PubMed ID: 12957610
[TBL] [Abstract][Full Text] [Related]
31. Imaging in Heart Transplant Patients.
Olymbios M; Kwiecinski J; Berman DS; Kobashigawa JA
JACC Cardiovasc Imaging; 2018 Oct; 11(10):1514-1530. PubMed ID: 30286911
[TBL] [Abstract][Full Text] [Related]
32. Oral steroid pulse without taper for the treatment of asymptomatic moderate cardiac allograft rejection.
Park MH; Starling RC; Ratliff NB; McCarthy PM; Smedira NS; Pelegrin D; Young JB
J Heart Lung Transplant; 1999 Dec; 18(12):1224-7. PubMed ID: 10612382
[TBL] [Abstract][Full Text] [Related]
33. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
[TBL] [Abstract][Full Text] [Related]
34. The repetitive histologic pattern of vascular cardiac allograft rejection. Increased incidence associated with longer exposure to prophylactic murine monoclonal anti-CD3 antibody (OKT3).
Ma H; Hammond EH; Taylor DO; Yowell RL; Bristow MR; O'Connell JB; Renlund DG
Transplantation; 1996 Jul; 62(2):205-10. PubMed ID: 8755817
[TBL] [Abstract][Full Text] [Related]
35. Increased transcript levels of TNF-alpha, TGF-beta, and granzyme B in endomyocardial biopsies correlate with allograft rejection.
Ramsperger-Gleixner M; Spriewald BM; Tandler R; Kondruweit M; Amann K; Weyand M; Ensminger SM
Exp Clin Transplant; 2011 Dec; 9(6):387-92. PubMed ID: 22142046
[TBL] [Abstract][Full Text] [Related]
36. A new rat infection-heart transplant model: effect of infection on graft survival studies.
Kobayashi J; Mavroudis C; Crawford SE; Zales VR; Backer CL
J Heart Lung Transplant; 1993; 12(4):659-64. PubMed ID: 7690253
[TBL] [Abstract][Full Text] [Related]
37. Impact of repetitive episodes of antibody-mediated or cellular rejection on cardiovascular mortality in cardiac transplant recipients: defining rejection patterns.
Kfoury AG; Stehlik J; Renlund DG; Snow G; Seaman JT; Gilbert EM; Stringham JS; Long JW; Hammond ME
J Heart Lung Transplant; 2006 Nov; 25(11):1277-82. PubMed ID: 17097489
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of the lymphocyte early activation marker CD69 in peripheral blood correlates with histologic evidence of cardiac allograft rejection.
Schowengerdt KO; Fricker FJ; Bahjat KS; Kuntz ST
Transplantation; 2000 May; 69(10):2102-7. PubMed ID: 10852605
[TBL] [Abstract][Full Text] [Related]
39. Cyclophosphamide in cardiac transplant recipients with frequent rejection: a six-year retrospective review.
Wagoner LE; Taylor DO; Olsen SL; Bristow MR; O'Connell JB; Hammond EH; Lappe DL; Renlund DG
Clin Transplant; 1996 Oct; 10(5):437-43. PubMed ID: 8930458
[TBL] [Abstract][Full Text] [Related]
40. Late acute cardiac allograft rejection: new therapeutic options?
Schweiger M; Wasler A; Prenner G; Tripolt M; Schwarz M; Tscheliessnigg KH
Transplant Proc; 2005 Dec; 37(10):4528-31. PubMed ID: 16387161
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
